Comparisons of cost-utility analyses for major diseases: A focus in the Australian context

This article delves into the nuances of cost-utility analyses applied to prevalent health conditions, examining the distinctive approaches for lung cancer, ischemic heart disease, and depressive disorders in Australia. The study explores the impact of utility-based units such as Disability-Adjusted Life Years, Quality-Adjusted Life Years, and Potential Years of Life Lost in economic evaluations. Notably, variations in disability weights and their implications on comparability are scrutinized, providing insights into the economic burden and cost-effectiveness of interventions. Findings reveal nuanced evaluation techniques’ critical importance and contextual relevance in health economic assessments.